IC
CLPT icon

Inscription Capital’s ClearPoint Neuro CLPT Stock Holding History

Inscription Capital’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+11,306
New +$141K 0.02% 704

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Inscription Capital's CLPT Position: Q2 2026 in Review

Inscription Capital opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 11,306 shares worth $202K. The stake represents 0.02% of the portfolio and ranks #704 among its holdings.

129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Inscription Capital held 11,306 shares of ClearPoint Neuro worth $202K as of Q2 2026.
  • ClearPoint Neuro was a new Inscription Capital position in Q2 2026.
  • ClearPoint Neuro made up 0.02% of Inscription Capital's portfolio in Q2 2026, its #704 holding.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.